Physical activity and 4-year changes in body weight in 52,498 non-obese people: the Lifelines cohort.

Leisure-time physical activity Life course Moderate-to-vigorous physical activity Occupational physical activity Physical activity Weight gain prevention

Journal

The international journal of behavioral nutrition and physical activity
ISSN: 1479-5868
Titre abrégé: Int J Behav Nutr Phys Act
Pays: England
ID NLM: 101217089

Informations de publication

Date de publication:
07 06 2021
Historique:
received: 21 01 2020
accepted: 20 05 2021
entrez: 8 6 2021
pubmed: 9 6 2021
medline: 3 7 2021
Statut: epublish

Résumé

We investigated associations between leisure-time physical activity (LTPA) at different intensities (moderate and vigorous or moderate-to-vigorous) and prospective weight gain in non-obese people. We also examined whether these associations were independent of other lifestyle factors and changes in muscle mass and whether they were age-dependent and changed over a person's life course. The data were extracted from the Lifelines cohort study (N = 52,498; 43.5% men) and excluded obese individuals (BMI > 30 kg/m The average weight gain was + 0.45 ± 0.03 kg in women. Relative to each reference groups (No-MVPA, No-MPA and No-VPA), MVPA (Beta (95%CI): - 0.34 kg (- 0.56;-0.13)), MPA (- 0.32 kg (- 0.54;-0.10)) and VPA (- 0.30 kg (- 0.43;-0.18)) were associated with less gain in body weight in women after adjusting for potential confounders, described above. These associations were dose-dependent when physically active individuals were divided in tertiles. Beta-coefficients (95%CI) for the lowest, middle, and highest MVPA tertiles relative to the 'No-MVPA' were, respectively, - 0.24 (- 0.47;-0.02), - 0.31 (- 0.53;-0.08), and - 0.38 (- 0.61;-0.16) kg. The average weight gain in men was + 0.13 ± 0.03 kg, and only VPA, not MPA was associated with less body weight gain. Beta-coefficients (95%CI) for the VPA tertiles relative to the 'No-VPA' group were, respectively, - 0.25 (- 0.42;-0.09), - 0.19 (- 0.38;-0.01) and - 0.20 (- 0.38;-0.02) kg. However, after adjusting for potential confounders, the association was no longer significant in men. The potential benefits of leisure-time PA were age-stratified and mainly observed in younger adults (men < 35 years) or stronger with younger age (women < 55 years). Higher leisure-time MVPA, MPA, and VPA were associated with less weight gain in women < 55 years. In younger men (< 35 years), only VPA was associated with less weight gain.

Identifiants

pubmed: 34098972
doi: 10.1186/s12966-021-01141-8
pii: 10.1186/s12966-021-01141-8
pmc: PMC8186174
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75

Références

JAMA. 2010 Mar 24;303(12):1173-9
pubmed: 20332403
Atherosclerosis. 2009 Dec;207(2):534-40
pubmed: 19535078
Br J Sports Med. 2014 Oct;48(20):1489-96
pubmed: 24782484
Nat Genet. 2010 Nov;42(11):937-48
pubmed: 20935630
J Endocrinol. 2009 Apr;201(1):151-9
pubmed: 19158129
J Am Heart Assoc. 2020 Feb 18;9(4):e014313
pubmed: 32067583
JAMA. 2010 Dec 15;304(23):2603-10
pubmed: 21156948
Int J Obes (Lond). 2015 Feb;39(2):199-207
pubmed: 24984753
PLoS One. 2013 Jul 24;8(7):e70684
pubmed: 23894679
Int J Obes (Lond). 2015 Jan;39(1):142-8
pubmed: 24732143
Am J Prev Med. 2017 Apr;52(4):e95-e101
pubmed: 28082000
Obesity (Silver Spring). 2013 Dec;21(12):E755-61
pubmed: 23512753
Int J Obes (Lond). 2009 Jul;33 Suppl 3:S1-92
pubmed: 19597430
Int J Obes Relat Metab Disord. 1993 May;17(5):279-86
pubmed: 8389337
Sports Med Int Open. 2017 Sep 06;1(5):E166-E171
pubmed: 30539103
Am J Clin Nutr. 2010 Sep;92(3):491-9
pubmed: 20573793
Sports Med. 1986 Sep-Oct;3(5):346-56
pubmed: 3529283
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Am J Gastroenterol. 2019 Jun;114(6):907-915
pubmed: 30865013
Mayo Clin Proc. 2016 Jun;91(6):735-44
pubmed: 27143482
J Clin Epidemiol. 1993 Dec;46(12):1403-11
pubmed: 8263567
J Cardiovasc Nurs. 2014 Nov-Dec;29(6):477-8
pubmed: 25290617
JAMA Cardiol. 2020 Dec 1;5(12):1323-1324
pubmed: 32745175
Int J Behav Nutr Phys Act. 2018 Jun 25;15(1):58
pubmed: 29940977
Int J Obes (Lond). 2017 Dec;41(12):1769-1774
pubmed: 28775377
Am J Prev Med. 2017 Dec;53(6):764-771
pubmed: 29032856
Med Sci Sports Exerc. 2013 Apr;45(4):706-13
pubmed: 23190592
Am J Clin Nutr. 2011 Apr;93(4):826-35
pubmed: 21346093
Obes Facts. 2015;8(6):402-24
pubmed: 26641646
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Adv Exp Med Biol. 2019;1121:61-66
pubmed: 31392653
PeerJ. 2017 Jan 19;5:e2902
pubmed: 28133575
Am J Cardiol. 2006 Jan 1;97(1):141-7
pubmed: 16377300
J Clin Epidemiol. 2003 Dec;56(12):1163-9
pubmed: 14680666
Am J Physiol. 1999 Sep;277(3):E489-95
pubmed: 10484361
J Clin Endocrinol Metab. 1992 Jul;75(1):157-62
pubmed: 1619005
Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):441-7
pubmed: 24438736
Eur J Clin Nutr. 2018 Aug;72(8):1111-1119
pubmed: 29895847
Eur J Epidemiol. 2008;23(1):67-74
pubmed: 18075776
Am J Clin Nutr. 2005 Dec;82(6):1253-9
pubmed: 16332658
Am J Clin Nutr. 2018 Nov 1;108(5):946-952
pubmed: 30475973

Auteurs

Oyuntugs Byambasukh (O)

Department of Epidemiology (FA40), Unit of Lifestyle Medicine in Obesity and Diabetes, University Medical Center Groningen, University of Groningen, P.O. Box 30 001, 9700, RB, Groningen, the Netherlands. o.byambasukh@umcg.nl.
Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia. o.byambasukh@umcg.nl.

Petra Vinke (P)

Department of Epidemiology (FA40), Unit of Lifestyle Medicine in Obesity and Diabetes, University Medical Center Groningen, University of Groningen, P.O. Box 30 001, 9700, RB, Groningen, the Netherlands.

Daan Kromhout (D)

Department of Epidemiology (FA40), Unit of Lifestyle Medicine in Obesity and Diabetes, University Medical Center Groningen, University of Groningen, P.O. Box 30 001, 9700, RB, Groningen, the Netherlands.

Gerjan Navis (G)

Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Eva Corpeleijn (E)

Department of Epidemiology (FA40), Unit of Lifestyle Medicine in Obesity and Diabetes, University Medical Center Groningen, University of Groningen, P.O. Box 30 001, 9700, RB, Groningen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH